Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1062

1.

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.

Thurman AR, Schwartz JL, Brache V, Clark MR, McCormick T, Chandra N, Marzinke MA, Stanczyk FZ, Dezzutti CS, Hillier SL, Herold BC, Fichorova R, Asin SN, Rollenhagen C, Weiner D, Kiser P, Doncel GF.

PLoS One. 2018 Jun 28;13(6):e0199778. doi: 10.1371/journal.pone.0199778. eCollection 2018.

2.

Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.

Sletten ET, Arnes M, Vereide AB, Ørbo A.

Anticancer Res. 2018 May;38(5):2883-2889.

PMID:
29715112
3.

Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system.

Schreiber CA, Teal SB, Blumenthal PD, Keder LM, Olariu AI, Creinin MD.

Eur J Contracept Reprod Health Care. 2018 Apr;23(2):116-120. doi: 10.1080/13625187.2018.1449825. Epub 2018 Mar 21.

4.

Magnetic resonance imaging and spectroscopy evidence of efficacy for adrenal and gonadal hormone replacement therapy in anorexia nervosa.

Vajapeyam S, Ecklund K, Mulkern RV, Feldman HA, O'Donnell JM, DiVasta AD, Rosen CJ, Gordon CM.

Bone. 2018 May;110:335-342. doi: 10.1016/j.bone.2018.02.021. Epub 2018 Feb 26.

PMID:
29496516
5.

Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.

Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ.

Clin Ther. 2018 Jan;40(1):64-73. doi: 10.1016/j.clinthera.2017.08.021. Epub 2017 Dec 2.

6.

Randomized trial of high- and low-fidelity simulation to teach intrauterine contraception placement.

Nippita S, Haviland MJ, Voit SF, Perez-Peralta J, Hacker MR, Paul ME.

Am J Obstet Gynecol. 2018 Feb;218(2):258.e1-258.e11. doi: 10.1016/j.ajog.2017.11.553. Epub 2017 Nov 11.

PMID:
29138033
7.

Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial.

Singata-Madliki M, Hofmeyr GJ, Carayon-Lefebvre d'Hellencourt F, Lawrie TA.

BMJ Open. 2017 Nov 12;7(11):e019205. doi: 10.1136/bmjopen-2017-019205.

8.

Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.

Akers AY, Steinway C, Sonalkar S, Perriera LK, Schreiber C, Harding J, Garcia-Espana JF.

Obstet Gynecol. 2017 Oct;130(4):795-802. doi: 10.1097/AOG.0000000000002242.

PMID:
28885425
9.

Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial.

Turok DK, Leeman L, Sanders JN, Thaxton L, Eggebroten JL, Yonke N, Bullock H, Singh R, Gawron LM, Espey E.

Am J Obstet Gynecol. 2017 Dec;217(6):665.e1-665.e8. doi: 10.1016/j.ajog.2017.08.003. Epub 2017 Aug 23.

10.

Absence of Effect of Intravaginal Miconazole, Clindamycin, Nonoxynol-9, and Tampons on the Pharmacokinetics of an Anastrozole/Levonorgestrel Intravaginal Ring.

Nave R, Klein S, Müller A, Chang X, Höchel J.

J Clin Pharmacol. 2018 Jan;58(1):97-106. doi: 10.1002/jcph.984. Epub 2017 Aug 7.

11.

Fast-track vs. delayed insertion of the levonorgestrel-releasing intrauterine system after early medical abortion - a randomized trial.

Korjamo R, Mentula M, Heikinheimo O.

Contraception. 2017 Nov;96(5):344-351. doi: 10.1016/j.contraception.2017.07.008. Epub 2017 Aug 5.

PMID:
28774663
12.

Hormonal Cycle and Contraceptive Effects on Amygdala and Salience Resting-State Networks in Women with Previous Affective Side Effects on the Pill.

Engman J, Sundström Poromaa I, Moby L, Wikström J, Fredrikson M, Gingnell M.

Neuropsychopharmacology. 2018 Feb;43(3):555-563. doi: 10.1038/npp.2017.157. Epub 2017 Jun 25.

PMID:
28741624
13.

Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.

Ibáñez L, Del Río L, Díaz M, Sebastiani G, Pozo ÓJ, López-Bermejo A, de Zegher F.

J Adolesc Health. 2017 Oct;61(4):446-453. doi: 10.1016/j.jadohealth.2017.04.010. Epub 2017 Jul 14.

PMID:
28712591
14.

Cardiovascular risk markers among obese women using the levonorgestrel-releasing intrauterine system: A randomised controlled trial.

Zueff LFN, Melo AS, Vieira CS, Martins WP, Ferriani RA.

Obes Res Clin Pract. 2017 Nov - Dec;11(6):687-693. doi: 10.1016/j.orcp.2017.06.001. Epub 2017 Jul 8.

PMID:
28693985
16.
17.

Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control.

Apter D, Zimmerman Y, Beekman L, Mawet M, Maillard C, Foidart JM, Coelingh Bennink HJT.

Eur J Contracept Reprod Health Care. 2017 Aug;22(4):260-267. doi: 10.1080/13625187.2017.1336532. Epub 2017 Jun 22.

PMID:
28641030
18.

Immediate versus delayed postpartum use of levonorgestrel contraceptive implants: a randomized controlled trial in Uganda.

Averbach S, Kakaire O, Kayiga H, Lester F, Sokoloff A, Byamugisha J, Dehlendorf C, Steinauer J.

Am J Obstet Gynecol. 2017 Nov;217(5):568.e1-568.e7. doi: 10.1016/j.ajog.2017.06.005. Epub 2017 Jun 10.

19.

A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial.

Zethraeus N, Dreber A, Ranehill E, Blomberg L, Labrie F, von Schoultz B, Johannesson M, Hirschberg AL.

Fertil Steril. 2017 May;107(5):1238-1245. doi: 10.1016/j.fertnstert.2017.02.120. Epub 2017 Apr 19.

PMID:
28433366

Supplemental Content

Loading ...
Support Center